ACADSTAFF UGM
| Title | : | Modulating the host immune response to fight against COVID-19: Where are we in 2021? |
| Author | : |
decsa medika hertanto (1) Henry Sutanto (2) Bayu Satria Wiratama, M.P.H., Ph.D (3) Citrawati Dyah Kencono Wungu (4) |
| Date | : | 5 2021 |
| Keyword | : | COVID-19,immune modulation COVID-19,immune modulation |
| Abstract | : | At present, while some countries are dealing with the continuously increasing incidence, some of the others are currently facing the 2019 coronavirus disease (COVID-19) resurgence, entering the second and third waves of the pandemic. Several determining factors could be attributed to such global phenomenon, including the emergence of novel severe acute respiratory syndrome-associated coronavirus type-2 (SARS-CoV-2) pathogenic variants (e.g. N501Y, E484K, B117 and N440K) and the nonexistence of effective pharmacological modalities for COVID-19. Despite the remarkable success of SARS-CoV-2 vaccines development, the treatment modalities for COVID-19 remains limited. Several repurposed drugs that were deemed to be useful were ineffective and even harmful [1,2]. Of those are the antimalarial drug chloroquine, antimicrobial azithromycin and protease inhibitors ritonavir/lopinavir, which were no longer recommended because of their potential cardiotoxicity [2,3]. |
| Group of Knowledge | : | Imunologi |
| Original Language | : | English |
| Level | : | Internasional |
| Status | : |
Published
|
| No | Title | Action |
|---|---|---|
| 1 |
21505594_2021 (1).pdf
Document Type : [PAK] Full Dokumen
|
View |